Anaphylactic reaction to cinoxacin: report of one case associated with inferior acute myocardial infarction

Eur Ann Allergy Clin Immunol. 2003 Feb;35(2):61-3.

Abstract

Cinoxacin is an oral synthetic antibacterial agent, of the second generation quinolones group, with excellent efficacy in respiratory, intra-abdominal, pelvic, and skin and soft tissue infections. Overall, quinolones are well tolerated drugs, although phototoxicity and photoallergenicity is well demonstrated experimentally. In this report we show you a case of a man who presented a anaphylactic reaction associated with myocardial infarction, after taking a capsule of cinoxacin. We suppose that there is a direct participation of the heart in anaphylactic reactions, because acttivated mast-cells mediators can determine cardiovascular effects. Then performed double-blind placebo controlled challenge test with an alternative drug. We did not observe any adverse immediate or late adverse reaction to this drug.

Publication types

  • Case Reports

MeSH terms

  • 4-Quinolones
  • Anaphylaxis / etiology*
  • Anti-Infective Agents / adverse effects*
  • Cinoxacin / adverse effects*
  • Double-Blind Method
  • Humans
  • Inflammation Mediators / metabolism
  • Male
  • Mast Cells / metabolism
  • Middle Aged
  • Myocardial Infarction / chemically induced*
  • Myocardial Infarction / immunology
  • Myocardial Infarction / pathology
  • Myocardium / immunology
  • Myocardium / pathology
  • Paresthesia / chemically induced
  • Postoperative Complications / drug therapy
  • Pruritus / chemically induced
  • Recurrence
  • Tongue Diseases / chemically induced
  • Urinary Bladder Neoplasms / surgery
  • Urinary Diversion
  • Urinary Tract Infections / drug therapy

Substances

  • 4-Quinolones
  • Anti-Infective Agents
  • Inflammation Mediators
  • Cinoxacin